XML 83 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
Loan and Security Agreement - Additional Information (Details) - USD ($)
12 Months Ended
Sep. 09, 2022
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]      
Debt instrument drew   $ 30,000,000  
Interest rate   12.82%  
Default interest rate 5.00%    
Interest expense   $ 3,800,000 $ 1,200,000
K2 Health Ventures [Member]      
Debt Instrument [Line Items]      
Principal amount $ 60,000,000    
Facility fee $ 400,000    
Additional principal amount percentage 1.00%    
Term loan maturity date Sep. 01, 2026    
Interest only payment term 24 months    
Interest only payment extended term 36 months    
Contractual interest rate 8.75%    
Interest rate 9.90% 9.90%  
Conversion price $ 4.785    
Final fee 6.00%    
Covenant terms   During the term of the Loan Agreement, the Company must maintain minimum unrestricted cash and cash equivalents equal to 5.0 times the average monthly cash burn measured over the trailing three-month period.  
K2 Health Ventures [Member] | Prime Rate [Member]      
Debt Instrument [Line Items]      
Prime rate 4.75%    
Tranche One [Member] | K2 Health Ventures [Member]      
Debt Instrument [Line Items]      
Debt instrument drew $ 30,000,000    
Tranche Two [Member] | K2 Health Ventures [Member]      
Debt Instrument [Line Items]      
Debt instrument remaining borrowing capacity 10,000,000    
Tranche Three [Member] | K2 Health Ventures [Member]      
Debt Instrument [Line Items]      
Debt instrument remaining borrowing capacity $ 20,000,000    
Maximum [Member] | K2 Health Ventures [Member]      
Debt Instrument [Line Items]      
Prepayment fee range 4.00%    
Minimum [Member] | K2 Health Ventures [Member]      
Debt Instrument [Line Items]      
Prepayment fee range 1.00%    
Covenant Terms, Unrestricted Cash and Cash Equivalents   $ 5,000,000